Ratings by Scotiabank (Louise Chen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2026 | Teva Pharma | TEVA | Maintain | Sector Outperform (N/A) |
|
Details | ||
| 12/5/2025 | Teva Pharma | TEVA | New Coverage | Sector Outperform (N/A) |
27.83 (32.03) |
15.09% | Details | |
| 6/6/2025 | Sarepta Therapeutics | SRPT | Upgrade | Sector Outperform (Sector Perform) |
39.54 (17.22) |
-56.45% | Details | |
| 6/2/2025 | Blueprint Medicines | BPMC | Downgrade | Sector Perform (Sector Outperform) |
101.35 (129.46) |
27.74% | Details | |
| 4/2/2025 | Edgewise Therapeutics | EWTX | Downgrade | Sector Perform (Sector Outperform) |
20.13 (39.76) |
97.52% | Details | |
| 3/20/2025 | Sarepta Therapeutics | SRPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/7/2025 | Sarepta Therapeutics | SRPT | New Coverage | Sector Perform (N/A) |
105.56 (17.22) |
-83.69% | Details | |
| 3/7/2025 | Palvella Therapeutics | PVLA | New Coverage | Sector Outperform (N/A) |
23.94 (157.24) |
556.81% | Details | |
| 3/7/2025 | Inova Technology, Inc. | INVA | New Coverage | Sector Outperform (N/A) |
17.59 (21.71) |
23.42% | Details | |
| 3/7/2025 | Gain Therapeutics | GANX | New Coverage | Sector Outperform (N/A) |
1.80 (1.71) |
-5% | Details | |
| 3/7/2025 | Edgewise Therapeutics | EWTX | New Coverage | Sector Outperform (N/A) |
28.13 (39.76) |
41.34% | Details | |
| 3/7/2025 | Dyne Therapeutics | DYN | New Coverage | Sector Outperform (N/A) |
12.24 (23.74) |
93.95% | Details | |
| 3/7/2025 | Avidity Biosciences | RNA | New Coverage | Sector Outperform (N/A) |
30.35 (12.15) |
-59.97% | Details | |
| 3/7/2025 | ARS Pharmaceuticals Inc | SPRY | New Coverage | Sector Outperform (N/A) |
10.79 (7.00) |
-35.13% | Details | |
| 3/7/2025 | Ardelyx, Inc | ARDX | New Coverage | Sector Outperform (N/A) |
5.32 (5.20) |
-2.26% | Details | |
| 3/7/2025 | Aclaris Therapeutis | ACRS | New Coverage | Sector Outperform (N/A) |
1.82 (5.68) |
212.09% | Details | |
| 3/7/2025 | Zai Lab | ZLAB | New Coverage | Sector Outperform (N/A) |
35.91 (20.20) |
-43.75% | Details | |
| 3/7/2025 | Blueprint Medicines | BPMC | New Coverage | Sector Outperform (N/A) |
89.92 (129.46) |
43.97% | Details | |
| 3/7/2025 | Cogent | COGT | New Coverage | Sector Outperform (N/A) |
7.67 (39.08) |
409.52% | Details |
